Back
ANI Pharmaceuticals Vs. Allogene Therapeutics Industry Stock Comparison
Sell
30
ANIP
ANI Pharmaceuticals
Last Price:
55.82
Seasonality Move:
6.25%
Sell
13
ALLO
Allogene Therapeutics
Last Price:
2.11
Seasonality Move:
6.59%
Sell
30
ANI Pharmaceuticals (ANIP)
is a Sell
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $55.86. The Score for ANIP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ANIP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Allogene Therapeutics (ALLO)
is a Sell
Is Allogene Therapeutics a Buy, Sell or Hold?
- The current Allogene Therapeutics [ALLO] share price is $2.11. The Score for ALLO is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- ALLO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $55.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANIP is experiencing slight buying pressure.
ALLO Stock Price Chart
What is Allogene Therapeutics's stock price today?
-
The Allogene Therapeutics share price today is $2.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANIP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.67 | Sell |
Relative Strength Index (14 RSI): | 42.15 | Sell |
Chaikin Money Flow: | 65847 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.5 - 60.24) | Sell |
Bollinger Bands (100): | (57.26 - 62.54) | Sell |
ALLO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 34.29 | Sell |
Chaikin Money Flow: | 1048716 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.34 - 3) | Sell |
Bollinger Bands (100): | (2.39 - 2.95) | Sell |
ANIP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.3 | Sell |
20-day SMA: | 58.06 | Sell |
50-day SMA: | 58.28 | Sell |
200-day SMA: | 62.15 | Sell |
8-day EMA: | 56.78 | Sell |
20-day EMA: | 57.75 | Sell |
50-day EMA: | 58.55 | Sell |
200-day EMA: | 59.7 | Sell |
ALLO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.34 | Sell |
20-day SMA: | 2.66 | Sell |
50-day SMA: | 2.7 | Sell |
200-day SMA: | 3.13 | Sell |
8-day EMA: | 2.32 | Sell |
20-day EMA: | 2.55 | Sell |
50-day EMA: | 2.65 | Sell |
200-day EMA: | 3.03 | Sell |
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.49 per share.
Allogene Therapeutics Earnings Growth & ALLO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.06 per share.
ANI Pharmaceuticals Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Allogene Therapeutics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |